A Novel p. Gly630Ser Mutation of COL2A1 in a Chinese Family with Presentations of Legg–Calvé–Perthes Disease or Avascular Necrosis of the Femoral Head

Objective Mutations in the type II collagen gene are associated with certain human disorders, collectively termed type II collagenopathies. They include Legg–Calvé–Perthes disease (LCPD) and avascular necrosis of the femoral head (ANFH). These two diseases are skeletal dysplasias, inherited in an autosomal dominant fashion, characterized by groin pain, dislocation of the hip and diminished joint mobility. Coxa vara and elevation of the greater trochanter of the femur comprise the typical phenotype of LCPD, but do not occur in ANFH. Lack of synthesis of type II collagen and structural defects are responsible for the major clinical outcomes, because collagen is the essential matrix protein of all connective tissues. Type II collagen, encoded by the COL2A1 gene, contains N- and C- terminal regions that are cleaved after secretion into the extracellular matrix, and the core area is composed of a triple helical (Gly–X–Y) domain. If the Gly in this specific region is replaced by other amino acids, the structure of type II collagen will be destroyed. Method Forty-five members of a four-generation family were recruited and investigated. Diagnosis was made by independent orthopedic surgeons and radiologists. A mutation of the COL2A1 gene was detected. Result In our research, we identify a heterozygous mutation (c.1888 G>A, p. Gly630Ser) in exon 29 of COL2A1 in the Gly–X–Y domain, in a Chinese family affected by LCPD and ANFH. Our findings provide significant clues to the phenotype–genotype relationships in these syndromes and may be helpful in clinical diagnosis. Furthermore, these results should assist further studies of the mechanisms underlying collagen diseases. Conclusion Our data add new variants to the repertoire of COL2A1 mutation resulting in related collagenopathies.

[1]  Jui-Sheng Sun,et al.  A mutation of the Col2a1 gene (G1170S) alters the transgenic murine phenotype and cartilage matrix homeostasis. , 2014, Journal of the Formosan Medical Association = Taiwan yi zhi.

[2]  R. Hennekam,et al.  Mutation‐based growth charts for SEDC and other COL2A1 related dysplasias , 2012, American journal of medical genetics. Part C, Seminars in medical genetics.

[3]  D. O’Rielly,et al.  Avascular necrosis of the femoral head due to a novel C propeptide mutation in COL2A1 , 2011, American journal of medical genetics. Part A.

[4]  M. Irving,et al.  Two Novel COL2A1 Mutations Associated with a Legg-Calvé-Perthes Disease-like Presentation , 2011, Clinical orthopaedics and related research.

[5]  Sheila Unger,et al.  Nosology and Classification of Genetic Skeletal Disorders: 2010 Revision , 2011, American journal of medical genetics. Part A.

[6]  A. Fertala,et al.  R992C (p.R1192C) Substitution in collagen II alters the structure of mutant molecules and induces the unfolded protein response. , 2009, Journal of molecular biology.

[7]  L. Bridgewater,et al.  The Heterozygous Disproportionate Micromelia (Dmm) Mouse: Morphological Changes in Fetal Cartilage Precede Postnatal Dwarfism and Compared With Lethal Homozygotes Can Explain the Mild Phenotype , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[8]  Nilesh Patil,et al.  Age at onset-dependent presentations of premature hip osteoarthritis, avascular necrosis of the femoral head, or Legg-Calvé-Perthes disease in a single family, consequent upon a p.Gly1170Ser mutation of COL2A1. , 2008, Arthritis and rheumatism.

[9]  H. Ohashi,et al.  A recurrent mutation in type II collagen gene causes Legg-Calvé-Perthes disease in a Japanese family , 2007, Human Genetics.

[10]  P. Bearcroft,et al.  Significant ocular findings are a feature of heritable bone dysplasias resulting from defects in type II collagen , 2007, British Journal of Ophthalmology.

[11]  T. Chow,et al.  Avascular necrosis of the femoral head: vascular hypotheses. , 2006, Endothelium : journal of endothelial cell research.

[12]  H. Ohashi,et al.  The phenotypic spectrum of COL2A1 mutations , 2005, Human mutation.

[13]  Ling-Hui Li,et al.  Type II collagen gene variants and inherited osteonecrosis of the femoral head. , 2005, The New England journal of medicine.

[14]  T. Aigner,et al.  Collagens--structure, function, and biosynthesis. , 2003, Advanced drug delivery reviews.

[15]  D. Eyre Articular cartilage and changes in Arthritis: Collagen of articular cartilage , 2001, Arthritis research.

[16]  P. Byers,et al.  Disruption of one intra-chain disulphide bond in the carboxyl-terminal propeptide of the proα1(I) chain of type I procollagen permits slow assembly and secretion of overmodified, but stable procollagen trimers and results in mild osteogenesis imperfecta , 2001, Journal of medical genetics.

[17]  G. Mortier,et al.  Report of five novel and one recurrentCOL2A1 mutations with analysis of genotype-phenotype correlation in patients with a lethal type II collagen disorder , 2000, Journal of medical genetics.

[18]  J. Bateman,et al.  Procollagen folding and assembly: the role of endoplasmic reticulum enzymes and molecular chaperones. , 1999, Seminars in cell & developmental biology.

[19]  D. Rimoin,et al.  An RNA-splicing mutation (G+5IVS20) in the type II collagen gene (COL2A1) in a family with spondyloepiphyseal dysplasia congenita. , 1995, American journal of human genetics.

[20]  K. Cheah,et al.  Expression of the mouse alpha 1(II) collagen gene is not restricted to cartilage during development. , 1991, Development.

[21]  M. Leppert,et al.  R-banding and nonisotopic in situ hybridization: precise localization of the human type II collagen gene (COL2A1) , 1990, Human Genetics.

[22]  P. Tsipouras,et al.  Spondyloepiphyseal dysplasia congenita: genetic linkage to type II collagen (COL2AI). , 1990, American journal of human genetics.

[23]  D. Keene,et al.  Type II achondrogenesis-hypochondrogenesis: morphologic and immunohistopathologic studies. , 1988, American journal of human genetics.

[24]  L. Ala‐Kokko,et al.  The Collagenopathies: Review of Clinical Phenotypes and Molecular Correlations , 2013, Current Rheumatology Reports.

[25]  H. Kuivaniemi,et al.  Mutations in fibrillar collagens (types I, II, III, and XI), fibril‐associated collagen (type IX), and network‐forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels , 1997, Human mutation.